Unlike many countries and regions in Europe, the United States and Asia Pacific where tobacco dependence is a separate disease and smoking cessation medications are included in the health insurance reimbursement list, China, the world’s largest producer and consumer of tobacco, has not yet included smoking cessation medications in its health insurance. In the face of the cold shoulder of smoking cessation clinics and the huge population of smokers, WHO recommends that China include smoking cessation medications in its health insurance so as to increase the number of people who quit smoking and improve the efficiency of quitting! However, studies have shown that after two years of implementing reimbursement for smoking cessation medications, smoking prevalence can be reduced by 1 to 2 percent, and after full reimbursement of smoking cessation treatment costs, smokers’ use of cessation treatment increases threefold and the number of successful quitters increases twofold after six months. Therefore, “including smoking cessation medications in health insurance, with partial or full reimbursement, would be an effective incentive for smokers to seek cessation treatment and make quit attempts.” On September 22, at a media briefing organized by the World Health Organization (WHO) Collaborating Centre on Tobacco or Health, Professor Xiao Dan of the WHO Collaborating Centre on Tobacco or Health emphasized that in China, including smoking cessation medications in health insurance and implementing reimbursement for smoking cessation medications would be far more cost-effective than antihypertensive, lipid-lowering, and sugar-lowering medications, and would have a shorter treatment period, faster and more effective, and could significantly reduce the burden of tobacco-related diseases. burden of tobacco-related diseases. In fact, the inclusion of smoking cessation drugs in the medical insurance is a long-standing call in the industry. in April 2012, the former Minister of Health Chen Zhu said, “will deepen the medical reform for tobacco control, and gradually include smoking cessation counseling and drugs in the basic medical insurance.” The reason for the delay in the inclusion, or as the former Vice Minister of Health Huang Jiefu said, “This requires the cooperation of the national health insurance department, not the health department can ‘say it all’.”